Mattel (MAT) FDA Approvals $14.32 -0.54 (-3.60%) As of 03:54 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share FDA Events Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mattel's Drug in the FDA Approval ProcessThis section highlights FDA-related milestones and regulatory updates for drugs developed by Mattel (MAT). Over the past two years, Mattel has reported clinical trial outcomes, regulatory submissions, approvals, and other FDA events for drugs and therapies such as Barbie. For definitions of regulatory abbreviations such as NDA, BLA, or PDUFA, see the event status legend. Barbie FDA Regulatory Events Barbie is a drug developed by Mattel for the following indication: type 1 diabetes (T1D). This drug is under review by the U.S. Food and Drug Administration (FDA). Below is a timeline of key regulatory milestones for this therapy. Provided Update - August 6,2025Provided Update Drug: BarbieAnnounced Date: August 6, 2025Indication: type 1 diabetes (T1D)AnnouncementMattel, Inc announced a partnership between its iconic Barbie™ brand and Quo Beauty®, the beloved and multi-award-winning Canadian beauty brand developed by Shoppers Drug Mart®. Available, August 11 nationwide, the all-new line includes colour cosmetics, cosmetic accessories, and hair accessories, all inspired by the Barbie™ brand's notable impact on beauty.AI SummaryOn August 11, Mattel, Inc. will launch a first-ever collaboration between its iconic Barbie™ brand and Quo Beauty®, the award-winning Canadian beauty line from Shoppers Drug Mart®. This nationwide release features a 23-piece collection of colour cosmetics, hair and cosmetic accessories, and more, all inspired by Barbie’s legacy of style and self-expression. Jennifer Gileno, Director of Licensing at Mattel Canada, says the partnership “celebrates our continued efforts to inspire the next generation to feel confident through self-expression.” Jenifer Gerlach Martin, Senior Director at Quo Beauty®, adds that the collaboration is “a milestone” reflecting shared values of confidence, playfulness, and inclusivity. The range includes hair sets with bow headbands and scrunchies, a mini curling iron kit, peptide lip tints in Iced Mocha and Watermelon, fast-dry nail enamels, blending sponges, bath and self-care sets, and a hard cosmetic case. Fans can find the collection exclusively at Shoppers Drug Mart®, Pharmaprix®, select Loblaw Real Canadian Superstores, and online.Read AnnouncementProvided Update - July 8,2025Provided Update Drug: BarbieAnnounced Date: July 8, 2025Indication: type 1 diabetes (T1D)AnnouncementMattel, Inc announced that Barbie® is debuting the first Barbie doll with type 1 diabetes (T1D).AI SummaryMattel, Inc. announced that Barbie® is debuting the first-ever Barbie doll with type 1 diabetes (T1D). Created in partnership with Breakthrough T1D, the doll is part of the global Fashionistas lineup and is designed to represent children living with T1D. The doll features realistic details such as a continuous glucose monitor on her arm, held in place by heart-shaped, Barbie pink medical tape, and an insulin pump attached to her waist. Her stylish blue polka dot outfit and matching accessories are nods to diabetes awareness, helping to foster inclusion and empathy through imaginative play. This pioneering doll allows more children to see themselves reflected in Barbie, empowering those with T1D by showing that life with the condition can be vibrant and full of possibilities. Barbie’s debut T1D doll highlights the brand’s ongoing commitment to representation and inclusivity.Read Announcement Mattel FDA Events - Frequently Asked Questions Has Mattel received FDA approval? As of now, Mattel (MAT) has not received any FDA approvals for its therapy in the last two years. What drugs has Mattel submitted to the FDA? In the past two years, Mattel (MAT) has reported FDA regulatory activity for Barbie. What is the most recent FDA event for Mattel? The most recent FDA-related event for Mattel occurred on August 6, 2025, involving Barbie. The update was categorized as "Provided Update," with the company reporting: "Mattel, Inc announced a partnership between its iconic Barbie™ brand and Quo Beauty®, the beloved and multi-award-winning Canadian beauty brand developed by Shoppers Drug Mart®. Available, August 11 nationwide, the all-new line includes colour cosmetics, cosmetic accessories, and hair accessories, all inspired by the Barbie™ brand's notable impact on beauty." What conditions do Mattel's current drugs treat? Currently, Mattel has one therapy (Barbie) targeting the following condition: type 1 diabetes (T1D). More FDA Event Resources from MarketBeat FDA Calendars Recent FDA Drug Approval Calendar Upcoming FDA Events & PDUFA Dates Calendar Companies With Recent FDA Events Candel Therapeutics FDA EventsCelcuity FDA EventsCingulate FDA EventsCo-Diagnostics FDA EventsCumberland Pharmaceuticals FDA EventsEvogene FDA EventsGilead Sciences FDA EventsGalmed Pharmaceuticals FDA EventsKaryopharm Therapeutics FDA EventsKura Oncology FDA EventsLantern Pharma FDA EventsQuoin Pharmaceuticals FDA EventsRezolute FDA EventsScienture FDA EventsVera Therapeutics FDA Events FDA Event Stage Terminology & Abbreviation Guide NDA: New Drug Application ANDA: Abbreviated New Drug Application sNDA: Supplemental New Drug Application BLA: Biologics License Application sBLA: Supplemental Biologics License Application FDA Approved: Approved by the FDA EMA: European Medicines Agency CE Mark: European Union Certification NMPA: China National Medical Products Administration MHLW: Japanese Ministry of Health FDA Meeting: Consultation with FDA Pre-IND: Pre-Investigational New Drug Meeting Breakthrough Therapy: Special FDA designation for promising therapies Fast Track: Accelerated FDA approval pathway Orphan Drug: Designation for rare disease treatments RPD: Rare Pediatric Disease Designation RMAT: Regenerative Medicine Advanced Therapy DSMB Review: Data Safety Monitoring Board Review IDMC Review: Independent Data Monitoring Committee MAA: MHRA Marketing Authorization Application RTF: Refusal to File (Rejected Application) 510(k): FDA Clearance for Medical Devices Rolling Submission: Staggered regulatory review process Stock Lists Biotechnology StocksCompare Biotech StocksCompare Healthcare StocksCompare Pharmaceutical StocksHealthcare and Medical Stocks FDA progress for NASDAQ:MAT last updated on 8/6/2025 by MarketBeat.com Staff. We continuously monitor for new FDA events and market data. From Our PartnersIf You Have $50k+ on Coinbase, This Will Ruin Your DayOctober 14th, 2025, CNBC quietly published an interview with BlackRock's CEO, who went on live television and ...Decentralized Masters | SponsoredHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredA gold storm is coming – are you ready?The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...Traders Agency | SponsoredFree: The Crypto Summit That Could Change Your LifeWe have assembled 27 of the top crypto experts in the world. Multi-millionaires, fund managers, coin creato...Crypto 101 Media | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredBNZI posted 169 percent revenue growth - is a turnaround formingBanzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mattel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mattel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Provided Update - August 6,2025Provided Update Drug: BarbieAnnounced Date: August 6, 2025Indication: type 1 diabetes (T1D)AnnouncementMattel, Inc announced a partnership between its iconic Barbie™ brand and Quo Beauty®, the beloved and multi-award-winning Canadian beauty brand developed by Shoppers Drug Mart®. Available, August 11 nationwide, the all-new line includes colour cosmetics, cosmetic accessories, and hair accessories, all inspired by the Barbie™ brand's notable impact on beauty.AI SummaryOn August 11, Mattel, Inc. will launch a first-ever collaboration between its iconic Barbie™ brand and Quo Beauty®, the award-winning Canadian beauty line from Shoppers Drug Mart®. This nationwide release features a 23-piece collection of colour cosmetics, hair and cosmetic accessories, and more, all inspired by Barbie’s legacy of style and self-expression. Jennifer Gileno, Director of Licensing at Mattel Canada, says the partnership “celebrates our continued efforts to inspire the next generation to feel confident through self-expression.” Jenifer Gerlach Martin, Senior Director at Quo Beauty®, adds that the collaboration is “a milestone” reflecting shared values of confidence, playfulness, and inclusivity. The range includes hair sets with bow headbands and scrunchies, a mini curling iron kit, peptide lip tints in Iced Mocha and Watermelon, fast-dry nail enamels, blending sponges, bath and self-care sets, and a hard cosmetic case. Fans can find the collection exclusively at Shoppers Drug Mart®, Pharmaprix®, select Loblaw Real Canadian Superstores, and online.Read Announcement
Provided Update - July 8,2025Provided Update Drug: BarbieAnnounced Date: July 8, 2025Indication: type 1 diabetes (T1D)AnnouncementMattel, Inc announced that Barbie® is debuting the first Barbie doll with type 1 diabetes (T1D).AI SummaryMattel, Inc. announced that Barbie® is debuting the first-ever Barbie doll with type 1 diabetes (T1D). Created in partnership with Breakthrough T1D, the doll is part of the global Fashionistas lineup and is designed to represent children living with T1D. The doll features realistic details such as a continuous glucose monitor on her arm, held in place by heart-shaped, Barbie pink medical tape, and an insulin pump attached to her waist. Her stylish blue polka dot outfit and matching accessories are nods to diabetes awareness, helping to foster inclusion and empathy through imaginative play. This pioneering doll allows more children to see themselves reflected in Barbie, empowering those with T1D by showing that life with the condition can be vibrant and full of possibilities. Barbie’s debut T1D doll highlights the brand’s ongoing commitment to representation and inclusivity.Read Announcement
Free MAT Stock Alerts